Abstract:It has been a great challenge to simultaneously inhibit the outgrowth of both the primary tumor and metastasis in metastatic cancer treatment. Substantial studies have evidenced that the interaction of platelets and cancer cells supports tumor metastasis, and platelets are considered to have metastasis-targeting property. Inspired by injury-targeting and metastasis-targeting properties of platelets, we constructed a photothermal therapy strategy with activated platelet-targeting albumin-based nanoparticles, PSN-HSA-PTX-IR780, to amplify drug delivery in the primary tumor at mild temperatures and simultaneously inhibit metastasis via a "platelet bridge". Human serum albumin (HSA) was premodified with a P-selectin-targeting peptide (PSN peptide) or IR780 serving as a photosensitizer. Hybrid albumin nanoparticles were assembled via the disulfide reprogramming method and encapsulated paclitaxel (PTX) to formulate PSN-HSA-PTX-IR780. The PSN-modified albumin nanoparticles could bind with upregulated P-selectin on activated platelets and subsequently target cancer cells by using platelets as a "bridge". In addition, nanoparticle-generated hyperthermia induced tissue injury and increased tumor-infiltrating platelets, thereby recruiting more nanoparticles into the tumor in a self-promoted way. In vivo studies showed that the drug accumulation of PSN-HSA-PTX-IR780 was 2.86-fold higher than that of HSA-PTX-IR780 at the optimal temperature (45 °C), which consequently improved the therapeutic outcome. Moreover, PSN-HSA-PTX-IR780 also effectively targets and inhibits lung metastasis by binding with metastasis-infiltrating platelets. Altogether, the self-promoted nanoplatform provides a unique and promising strategy for metastatic cancer treatment with enhanced drug delivery efficacy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c04442?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c04442</a>.Synthesis route and 1H-NMR spectra of IR780SCOOH; 13C-NMR spectra and mass spectra; UV–vis–NIR absorbance and fluorescence emission spectra and temperature change curves of IR780 and IR780SCOOH; MALDI-TOF-MS spectra of HSA-IR780 and PSN-HSA; circular dichroism spectra; PTX release profiles; SEM images; cellular uptake of 4T1 cells; pharmacokinetic profiles; H&E staining images; hematology and blood biochemistry analysis (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c04442/suppl_file/am1c04442_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Augment the Efficacy of Eradicating Metastatic Lesions and Tumor Proliferation in Breast Cancer by Honokiol-Loaded Ph-Sensitive Targeted Lipid Nanoparticles

Polysialic Acid-Functionalized Liposomes for Efficient Honokiol Delivery to Inhibit Breast Cancer Growth and Metastasis.

Herb-Nanoparticle Hybrid System for Improved Oral Delivery Efficiency to Alleviate Breast Cancer Lung Metastasis

Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.

Synergistically Enhanced Antimetastasis Effects by Honokiol-Loaded pH-Sensitive Polymer-Doxorubicin Conjugate Micelles.

Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis

Stimuli-sensitive Biomimetic Nanoparticles for the Inhibition of Breast Cancer Recurrence and Pulmonary Metastasis

Hypoxia-Responsive Stereocomplex Polymeric Micelles with Improved Drug Loading Inhibit Breast Cancer Metastasis in an Orthotopic Murine Model.

Enhanced Anti-Metastatic Therapy with Down-Regulation of Heparinase Expression by ROS-responsive Micellar Nanoparticles.

Primary Tumor and Pre-Metastatic Niches Co-Targeting "Peptides-Lego" Hybrid Hydroxyapatite Nanoparticles for Metastatic Breast Cancer Treatment

Novel Nanosystem to Enhance the Antitumor Activity of Lapatinib in Breast Cancer Treatment: Therapeutic Efficacy Evaluation.

Enhanced Anti-Tumor and Anti-Metastasis Efficacy Against Breast Cancer with an Intratumoral Injectable Phospholipids-Based Phase Separation Gel Co-Loaded with 5-Fluotouracil and Magnesium Oxide by Neutralizing Acidic Microenvironment.

Low Molecular Weight Heparin-Based Reduction-Sensitive Nanoparticles for Antitumor and Anti-Metastasis of Orthotopic Breast Cancer.

Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment

Fe3O4 liposome for photothermal/chemo-synergistic inhibition of metastatic breast tumor

Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy

Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced “Platelet Bridge”

Effective treatment of metastatic sentinel lymph nodes by dual-targeting melittin nanoparticles

Fe<sub>3</sub>O<sub>4</sub> liposome for photothermal/chemo-synergistic inhibition of metastatic breast tumor

Liposomal Codelivery of Doxorubicin and Andrographolide Inhibits Breast Cancer Growth and Metastasis

Stimuli-responsive polymeric prodrug-based nanomedicine delivering nifuroxazide and doxorubicin against primary breast cancer and pulmonary metastasis